Insulet Corporation

• The Case for Evaluating Continuous Glucose Monitoring as a Diagnostic Tool for Diabetes

  Consulting or advice, Fees or honoraria, Board or leadership role, 8 Oct 2026

• Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study

  Fees or honoraria, 31 Aug 2026

• Trends in type 2 diabetes incidence and BMI at diagnosis by age, sex, and ethnicity, 2011-2024: a population-based analysis of the English National Diabetes Audit

  Consulting or advice, Board or leadership role, 22 Jul 2026

• Glucagon receptor signaling is indispensable for the healthspan effects of caloric restriction in aging male mice

  Consulting or advice, Fees or honoraria, 25 Sept 2025

Sources: pubmed.ncbi.nlm.nih.gov

• Cardiovascular Outcomes Associated with GLP-1 Receptor Agonist Use among Adults with Type 1 Diabetes and Overweight or Obesity: A Target Trial Emulation Using Real-World EHR Data

  ADA Scientific Sessions 2026 abstract, 8 Jun 2026

• More Than Hot Flashes: Menopause Stages and Diabetes Management Burden

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Prevalence and Characterization of Underlying Preoperative Dysglycemia in Surgical Patients without Diabetes

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Libre 2 CGM plus Glycemic Excursion Minimization (GEM) in the Treatment of Prediabetes (the IMPEDE Study)

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Higher Risk of Noncardiovascular Death in a Population-Based Cohort of Type 1 Diabetes

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025